← back to search

Peter A. Nigrović

Harvard University · US
Area of research
Rheumatology · Hematology
Research interest
Research interests include Autoimmune and Inflammatory Disorders Research, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, and Adolescent and Pediatric Healthcare.
h-index
71
citations
19,642
works
433
NIH funding
primary concept
Medicine
email

Recent publications

TAK1 inhibition restores p53 expression and suppresses inflammation and hyperplasia in JIA synovial fibroblasts.
2026cited by 0position: contributordoi
Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants.
2026cited by 0position: contributordoi
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies
Blood Immunology & Cellular Therapy 2026cited by 0position: contributordoi
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines
Nature Immunology 2026cited by 0position: contributordoi
From complexity to consensus: A roadmap for neutrophil classification
Immunity 2025cited by 25position: middledoi
Macrophage Activation Syndrome.
2025cited by 12position: contributordoi
The 'T<sub>reg</sub> paradox' in inflammatory arthritis.
2025cited by 11position: contributordoi
Early transcriptional effects of inflammatory cytokines reveal highly redundant cytokine networks.
2025cited by 7position: contributordoi
Adipose tissue harbors pathogenic T cells in obesity that exacerbate inflammatory arthritis.
2025cited by 3position: contributordoi
A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis
2025cited by 3position: contributordoi
A multi-omics resource of B cell activation reveals genetic mechanisms for immune-mediated diseases
2025cited by 1position: contributordoi
The joint accumulation model of arthritis.
2025cited by 0position: contributordoi
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis.
2025cited by 0position: contributordoi
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies
2025cited by 0position: contributordoi
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
Annals of the Rheumatic Diseases 2024cited by 151position: middledoi
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.
2024cited by 93position: contributordoi
Recent advances and evolving concepts in Still’s disease
Nature Reviews Rheumatology 2024cited by 62position: middledoi
Recent advances and evolving concepts in Still's disease.
2024cited by 41position: contributordoi
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders.
2024cited by 30position: contributordoi
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis
Arthritis & Rheumatology 2024cited by 16position: middledoi
Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis.
2024cited by 15position: contributordoi
The ‘Treg paradox’ in inflammatory arthritis
Nature Reviews Rheumatology 2024cited by 13position: lastdoi
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.
2024cited by 11position: contributordoi
Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development.
2024cited by 9position: contributordoi
High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus.
2024cited by 8position: contributordoi
The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease.
2024cited by 3position: contributordoi
Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework.
2024cited by 1position: contributordoi
"Rounding Third Base and Heading Home": Arthritis & Rheumatology in 2024.
2024cited by 0position: contributordoi
Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts.
2023cited by 46position: contributordoi
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome
Journal of Clinical Investigation 2023cited by 38position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 55 papers (2019–2026)Lauren A. Henderson · Boston Children's Hospital10 papers (2020–2026)Pui Y. Lee · Dana-Farber/Boston Children's Cancer and Blood Disorders Center9 papers (2020–2026)Timothy Beukelman · University of Alabama at Birmingham9 papers (2012–2019) · 8 papers (2020–2026)Margaret H. Chang · Brigham and Women's Hospital7 papers (2020–2025)Jeffrey A. Sparks · Harvard University7 papers (2022–2025)Pamela F. Weiss · Hospital for Sick Children6 papers (2012–2022)Deepak A. Rao · Stanford University6 papers (2019–2024) · 6 papers (2021–2022)Fatma Dedeoglu · Boston Children's Hospital6 papers (2021–2026)Matthew L. Stoll · University of Alabama at Birmingham6 papers (2012–2022)Yukiko Kimura · Nationwide Children's Hospital6 papers (2012–2018)Daniel J. Lovell · Wake Forest University6 papers (2013–2019)Pierre Cunin · Wisconsin Division of Public Health5 papers (2017–2023) · 5 papers (2019–2022)Holly Wobma · Boston Children's Hospital5 papers (2023–2026) · 5 papers (2022–2025)Felix A. Radtke · University of Oxford5 papers (2021–2023)Mindy S. Lo · Boston Children's Hospital5 papers (2021–2025)